Hinova Pharmaceuticals Statistics

Total Valuation

SHA:688302 has a market cap or net worth of CNY 4.04 billion. The enterprise value is 3.31 billion.

Market Cap	4.04B
Enterprise Value	3.31B

Important Dates

The last earnings date was Saturday, April 25, 2026.

Earnings Date	Apr 25, 2026
Ex-Dividend Date	n/a

Share Statistics

SHA:688302 has 99.02 million shares outstanding. The number of shares has decreased by -1.18% in one year.

Current Share Class	99.02M
Shares Outstanding	99.02M
Shares Change (YoY)	-1.18%
Shares Change (QoQ)	+2.13%
Owned by Insiders (%)	20.16%
Owned by Institutions (%)	19.60%
Float	71.83M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	86.80
PB Ratio	3.90
P/TBV Ratio	4.02
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-24.54
EV / Sales	71.26
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-22.20

Financial Position

The company has a current ratio of 7.04, with a Debt / Equity ratio of 0.10.

Current Ratio	7.04
Quick Ratio	6.65
Debt / Equity	0.10
Debt / EBITDA	n/a
Debt / FCF	-0.70
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -12.29% and return on invested capital (ROIC) is -8.16%.

Return on Equity (ROE)	-12.29%
Return on Assets (ROA)	-7.26%
Return on Invested Capital (ROIC)	-8.16%
Return on Capital Employed (ROCE)	-12.99%
Weighted Average Cost of Capital (WACC)	3.93%
Revenue Per Employee	267,215
Profits Per Employee	-776,051
Employee Count	174
Asset Turnover	0.04
Inventory Turnover	0.12

Taxes

In the past 12 months, SHA:688302 has paid 4,154 in taxes.

Income Tax	4,154
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +4.97% in the last 52 weeks. The beta is -0.04, so SHA:688302's price volatility has been lower than the market average.

Beta (5Y)	-0.04
52-Week Price Change	+4.97%
50-Day Moving Average	43.08
200-Day Moving Average	50.14
Relative Strength Index (RSI)	40.36
Average Volume (20 Days)	1,952,210

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHA:688302 had revenue of CNY 46.50 million and -135.03 million in losses. Loss per share was -1.37.

Revenue	46.50M
Gross Profit	46.17M
Operating Income	-150.81M
Pretax Income	-135.03M
Net Income	-135.03M
EBITDA	-146.06M
EBIT	-150.81M
Loss Per Share	-1.37

Full Income Statement

Balance Sheet

The company has 827.74 million in cash and 105.04 million in debt, giving a net cash position of 722.71 million or 7.30 per share.

Cash & Cash Equivalents	827.74M
Total Debt	105.04M
Net Cash	722.71M
Net Cash Per Share	7.30
Equity (Book Value)	1.03B
Book Value Per Share	10.38
Working Capital	755.75M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -84.75 million and capital expenditures -64.46 million, giving a free cash flow of -149.21 million.

Operating Cash Flow	-84.75M
Capital Expenditures	-64.46M
Depreciation & Amortization	4.76M
Net Borrowing	100.00M
Free Cash Flow	-149.21M
FCF Per Share	-1.51

Full Cash Flow Statement

Margins

Gross margin is 99.29%, with operating and profit margins of -324.36% and -290.42%.

Gross Margin	99.29%
Operating Margin	-324.36%
Pretax Margin	-290.41%
Profit Margin	-290.42%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SHA:688302 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.18%
Shareholder Yield	1.18%
Earnings Yield	-3.35%
FCF Yield	-3.70%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2